Insider Selling: Phreesia, Inc. (NYSE:PHR) COO Sells 10,716 Shares of Stock

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 10,716 shares of the business’s stock in a transaction on Monday, January 27th. The stock was sold at an average price of $27.48, for a total transaction of $294,475.68. Following the completion of the sale, the chief operating officer now owns 764,307 shares of the company’s stock, valued at $21,003,156.36. The trade was a 1.38 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

Evan Roberts also recently made the following trade(s):

• On Tuesday, January 21st, Evan Roberts sold 12,749 shares of Phreesia stock. The stock was sold at an average price of $27.31, for a total transaction of $348,175.19.
• On Wednesday, January 15th, Evan Roberts sold 1,785 shares of Phreesia stock. The shares were sold at an average price of $26.98, for a total value of $48,159.30.
• On Wednesday, January 8th, Evan Roberts sold 2,681 shares of Phreesia stock. The shares were sold at an average price of $27.95, for a total value of $74,933.95.
• On Monday, January 6th, Evan Roberts sold 2,873 shares of Phreesia stock. The stock was sold at an average price of $26.61, for a total transaction of $76,450.53.

Phreesia Stock Down 1.7 %

Shares of PHR opened at $28.81 on Thursday. The firm has a market capitalization of $1.67 billion, a price-to-earnings ratio of -19.60 and a beta of 0.94. Phreesia, Inc. has a 52 week low of $17.07 and a 52 week high of $29.90. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74. The business’s fifty day moving average price is $24.57 and its two-hundred day moving average price is $23.20.

Phreesia (NYSE:PHR) last announced its quarterly earnings data on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, topping the consensus estimate of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The firm had revenue of $106.80 million during the quarter, compared to analysts’ expectations of $106.33 million. During the same period in the previous year, the business posted ($0.58) EPS. The company’s quarterly revenue was up 16.6% compared to the same quarter last year. On average, analysts predict that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Analyst Ratings Changes

Several equities research analysts recently weighed in on PHR shares. Citigroup increased their target price on shares of Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a research note on Friday, January 10th. Piper Sandler reissued an “overweight” rating and issued a $33.00 target price (up from $31.00) on shares of Phreesia in a report on Wednesday. Truist Financial boosted their price target on Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. Needham & Company LLC reiterated a “buy” rating and issued a $29.00 price target on shares of Phreesia in a research report on Friday, January 10th. Finally, JMP Securities reissued a “market outperform” rating and set a $30.00 price objective on shares of Phreesia in a report on Tuesday, December 10th. Thirteen equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $31.15.

Hedge Funds Weigh In On Phreesia

Large investors have recently bought and sold shares of the business. R Squared Ltd bought a new stake in shares of Phreesia during the 4th quarter valued at $30,000. International Assets Investment Management LLC increased its holdings in Phreesia by 2,179.7% in the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock valued at $33,000 after purchasing an additional 1,395 shares during the last quarter. XTX Topco Ltd bought a new position in Phreesia during the third quarter worth about $247,000. Hsbc Holdings PLC acquired a new position in shares of Phreesia during the 2nd quarter worth about $301,000. Finally, Intech Investment Management LLC bought a new stake in shares of Phreesia in the 3rd quarter valued at about $316,000. 92.10% of the stock is currently owned by institutional investors and hedge funds.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.